Basel, Switzerland

Marcel Scheer

This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1976.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Marcel Scheer: Innovator in Pharmaceutical Chemistry

Introduction

Marcel Scheer is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Marcel Scheer holds 2 patents that showcase his innovative work. His latest patents include a process for the preparation of L-Dopa, which is an effective agent in the treatment of Parkinson's Disease. This invention utilizes D,L-N-benzoyl-3-(4-hydroxy-3-methoxyphenyl) alanine and dehydroabietylamine as a resolving agent. Another patent involves the process for obtaining dihydroxy coumarin derivatives, which are useful for lowering blood pressure and for chemical sympathectomy. This process involves oxidizing specific dihydroxyphenyl-propionic acid derivatives.

Career Highlights

Marcel Scheer is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

He has collaborated with notable coworkers such as Ado Kaiser and Werner Hausermann, further enhancing the innovative environment in which he works.

Conclusion

Marcel Scheer's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to impact the treatment of various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…